Clinical Trial Shows Teriflunomide Pill Reduces Relapses in Relapsing-Remitting MS (1)/About-the-Society/News/Clinical-Trial-Shows-Teriflunomide-Pill-Reduce-(1) … read morePosted At: National MS Society
Medical history reveals multiple sclerosis begins to impact patients soonerPeople with multiple sclerosis can show signs of something wrong five years before the onset of disease, much earlier than previously thought, according to a...
National MS Society Responds to President’s Proposed FY 2018 Budget/About-the-Society/News/National-MS-Society-Responds-to-President’s-Propos … read morePosted At: National MS Society
Researchers Continue With Their Progress in the Seven Society-Funded CCSVI Studies in MS/About-the-Society/News/Researchers-Continue-With-Their-Progress-in-the-Se … read morePosted At: National MS Society
Emerging Therapies, Wellness, Progression and Other MS Research News from AAN Meeting/About-the-Society/News/Emerging-Therapies,-Wellness,-Progression-and-Othe … read morePosted At: National MS Society
- Next story Significant New York Times Feature Details Impact of MS
- Previous story Results Published From Small Clinical Trial of Adult Stem Cells in People with Relapsing MS
Join Our Mailing List
- Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis
- What are the early signs of MS?
- Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis
- Treatment decisions in MS: Shifting the goal posts or changing how we see them?
- How to give an intramuscular injection
- Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry
- e-Health and multiple sclerosis: An update
- Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System
- Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis
- MS: Is a ‘rogue’ brain and lymph node interaction to blame?